CL - Colgate-Palmolive Co Stock Price, Fair Value and News

86.75USD+0.58 (+0.67%)Market Closed

Market Summary

USD86.75+0.58

Market Closed

0.67%

CL Stock Price

View Fullscreen

CL RSI Chart

CL Valuation

Market Cap

71.4B

Price/Earnings (Trailing)

31.05

Price/Sales (Trailing)

3.67

EV/EBITDA

18.47

Price/Free Cashflow

19.07

CL Price/Sales (Trailing)

CL Profitability

Operating Margin

58.21%

EBT Margin

17.43%

Return on Equity

377.67%

Return on Assets

14.03%

Free Cashflow Yield

5.24%

CL Fundamentals

CL Revenue

Revenue (TTM)

19.5B

Rev. Growth (Yr)

6.93%

Rev. Growth (Qtr)

0.71%

CL Earnings

Earnings (TTM)

2.3B

Earnings Growth (Yr)

14.3K%

Earnings Growth (Qtr)

1.41%

Breaking Down CL Revenue

Last 7 days

0.2%

Last 30 days

-1.7%

Last 90 days

7.3%

Trailing 12 Months

15.6%

How does CL drawdown profile look like?

CL Financial Health

Current Ratio

1.11

Debt/Equity

13.5

Debt/Cashflow

0.46

CL Investor Care

Dividend Yield

2.2%

Dividend/Share (TTM)

1.91

Buy Backs (1Y)

0.87%

Diluted EPS (TTM)

2.78

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	18.3B	18.7B	19.1B	19.5B
2022	17.5B	17.7B	17.7B	18.0B
2021	16.7B	17.1B	17.3B	17.4B
2020	15.9B	15.9B	16.2B	16.5B
2019	15.4B	15.4B	15.5B	15.7B
2018	15.7B	15.8B	15.6B	15.5B
2017	15.2B	15.2B	15.3B	15.5B
2016	15.7B	15.5B	15.4B	15.2B
2015	17.0B	16.7B	16.4B	16.0B
2014	17.4B	17.4B	17.4B	17.3B
2013	17.2B	17.3B	17.3B	17.4B
2012	16.9B	17.0B	17.0B	17.1B
2011	15.7B	16.1B	16.5B	16.7B
2010	15.7B	15.7B	15.7B	15.6B
2009	15.1B	14.9B	14.9B	15.3B
2008	0	14.3B	14.8B	15.3B
2007	0	0	0	13.8B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Colgate-Palmolive Co

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 01, 2024	bilbrey john p	acquired	21,206	88.36	240	-
Apr 01, 2024	norrington lorrie m	acquired	26,242	88.36	297	-
Apr 01, 2024	edwards lisa	acquired	9,366	88.36	106	-
Apr 01, 2024	newman brian	acquired	18,732	88.36	212	-
Feb 20, 2024	wallace noel r.	acquired	3,781,930	68.16	55,486	chairman, president & ceo
Feb 20, 2024	daniels jennifer	sold	-299,578	84.6745	-3,538	clo and secretary
Feb 20, 2024	wallace noel r.	sold	-5,890,890	84.2181	-69,948	chairman, president & ceo
Feb 18, 2024	malcolm gregory	sold (taxes)	-21,871	83.48	-262	evp and controller
Feb 18, 2024	kooyman john w	sold (taxes)	-59,771	83.48	-716	chief of staff
Feb 18, 2024	tsourapas panagiotis	sold (taxes)	-287,756	83.48	-3,447	grp pres, eur& developing mkts

Which funds bought or sold CL recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 16, 2024	First International Bank & Trust	reduced	-2.04	23,309	241,874	0.08%
Apr 16, 2024	Reliant Investment Management, LLC	unchanged	-	39,292	342,190	0.16%
Apr 16, 2024	GUYASUTA INVESTMENT ADVISORS INC	reduced	-0.74	-31,485	4,236,110	0.31%
Apr 16, 2024	TRUST CO OF VIRGINIA /VA	reduced	-4.11	56,528	735,257	0.07%
Apr 16, 2024	FLAGSHIP HARBOR ADVISORS, LLC	reduced	-16.13	-48,327	871,080	0.06%
Apr 16, 2024	Perpetual Ltd	reduced	-2.01	83,781	867,091	0.01%
Apr 16, 2024	AMF Tjanstepension AB	unchanged	-	2,234,740	19,477,700	0.15%
Apr 16, 2024	COUNTRY TRUST BANK	added	245	2,545	3,422	-%
Apr 16, 2024	Pinnacle Bancorp, Inc.	unchanged	-	15,572	135,615	0.04%
Apr 16, 2024	Register Financial Advisors LLC	new	-	48,357	48,357	0.03%

Are Funds Buying or Selling CL?

Are funds buying CL calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own CL

No. of Funds

Unveiling Colgate-Palmolive Co's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	9.70%	79,893,294	SC 13G/A
Jan 26, 2024	blackrock inc.	6.8%	56,170,766	SC 13G/A
Jan 25, 2024	state street corp	5.79%	47,641,721	SC 13G/A
Feb 09, 2023	vanguard group inc	9.62%	80,375,011	SC 13G/A
Feb 06, 2023	state street corp	5.97%	49,899,351	SC 13G/A
Feb 03, 2023	blackrock inc.	8.1%	68,041,416	SC 13G/A
Feb 14, 2022	state street corp	5.89%	49,608,335	SC 13G/A
Feb 09, 2022	vanguard group inc	9.11%	76,746,614	SC 13G/A
Feb 01, 2022	blackrock inc.	7.7%	65,218,485	SC 13G/A
Feb 12, 2021	state street corp	5.92%	50,722,444	SC 13G

Recent SEC filings of Colgate-Palmolive Co

View All Filings

Date Filed	Form Type	Document
Apr 03, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading
Mar 27, 2024	ARS	ARS
Mar 27, 2024	DEF 14A	DEF 14A
Mar 27, 2024	DEFA14A	DEFA14A
Mar 22, 2024	3	Insider Trading
Feb 20, 2024	4	Insider Trading
Feb 20, 2024	4	Insider Trading

Peers (Alternatives to Colgate-Palmolive Co)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
PG	369.3B	83.9B	-2.65%	4.44%	25	4.4	4.55%	3.44%
CL	71.4B	19.5B	-1.72%	15.57%	31.05	3.67	8.29%	28.85%
EL	49.5B	15.2B	-6.58%	-46.28%	102.53	3.27	-7.33%	-68.01%
CHD	25.2B	5.9B	-0.78%	15.72%	33.38	4.3	9.16%	82.56%
CLX	17.7B	7.3B	-4.42%	-11.35%	220.71	2.42	3.47%	-81.61%
COTY	9.5B	6.0B	-12.16%	-15.24%	29.36	1.58	14.07%	132.95%
ELF	9.2B	890.1M	-15.52%	79.63%	71.35	10.37	79.24%	176.22%
MID-CAP
IPAR	4.0B	1.3B	-7.30%	-17.28%	25.93	3	21.26%	26.23%
NWL	2.9B	8.1B	-9.53%	-44.05%	-7.4	0.35	-14.02%	-296.95%
HIMS	2.6B	872.0M	-20.85%	12.82%	-110.34	2.98	65.49%	64.15%
HELE	2.3B	2.0B	-15.84%	10.43%	14.09	1.14	-7.82%	10.32%
SMALL-CAP
EPC	1.8B	2.3B	-4.87%	-17.84%	16.47	0.78	4.31%	6.67%
ACU	157.3M	191.5M	8.25%	71.91%	8.84	0.82	-1.27%	486.29%
GROV	54.3M	259.3M	-14.75%	212.00%	-1.26	0.21	-19.36%	50.71%
UG	36.1M	10.9M	2.08%	-17.91%	13.99	3.32	-14.28%	0.46%

Colgate-Palmolive Co News

Latest updates

Colgate-Palmolive Co Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	0.7%	4,950	4,915	4,822	4,770	4,629	4,455	4,484	4,399	4,403	4,414	4,260	4,344	4,324	4,153	3,897	4,097	4,015	3,928	3,866	3,884	3,811
Cost Of Revenue	-1.9%	2,000	2,038	2,035	2,058	2,055	1,907	1,930	1,827	1,844	1,791	1,704	1,707	1,681	1,613	1,528	1,632	1,601	1,612	1,558	1,597	1,558
Gross Profit	2.5%	2,950	2,877	2,787	2,712	2,574	2,548	2,554	2,572	2,559	2,623	2,556	2,637	2,643	2,540	2,369	2,465	2,414	2,316	2,308	2,287	2,253
S&GA Expenses	-1.0%	1,803	1,822	1,768	1,758	1,633	1,634	1,657	1,641	1,598	1,636	1,568	1,605	1,633	1,518	1,395	1,473	1,412	1,429	1,369	1,365	1,328
EBITDA Margin	-	0.22*	-	0.17*	0.17*	0.19*	0.20*	0.20*	0.21*	0.22*	0.25*	0.26*	0.27*	0.27*	0.27*	0.26*	0.26*	0.26*	0.26*	0.26*	0.26*	-
Interest Expenses	-50.9%	56.00	114	-	-	68.00	39.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Taxes	9.1%	228	209	353	147	89.00	210	202	192	136	172	212	229	202	222	216	147	188	167	205	214	189
Earnings Before Taxes	3.3%	988	956	887	561	132	892	841	795	324	853	953	957	894	967	891	895	870	794	823	814	832
EBT Margin	31.5%	0.17*	0.13*	0.13*	0.13*	0.15*	0.16*	0.16*	0.17*	0.18*	0.21*	0.22*	0.22*	0.22*	0.22*	0.22*	0.21*	0.21*	0.21*	0.21*	-	-
Net Income	1.4%	718	708	502	372	5.00	618	603	559	148	634	703	681	647	698	635	715	643	578	586	560	606
Net Income Margin	42.5%	0.12*	0.08*	0.08*	0.09*	0.10*	0.11*	0.11*	0.12*	0.12*	0.15*	0.16*	0.16*	0.16*	0.17*	0.16*	0.16*	0.15*	0.15*	0.15*	-	-
Free Cashflow	-1.4%	1,136	1,152	722	735	673	969	528	386	1,106	994	627	598	963	962	1,026	768	970	914	644	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	2.2%	16,393	16,043	16,227	16,173	15,731	16,288	15,711	15,723	15,040	15,880	15,999	15,801	15,920	15,466	15,141	15,070	15,034	15,026	13,151	12,883	12,161
Current Assets	-1.5%	5,279	5,357	5,437	5,466	5,113	5,278	5,160	4,989	4,397	4,670	4,652	4,563	4,338	4,367	4,212	4,248	4,179	4,349	4,255	4,133	3,793
Cash Equivalents	1.6%	966	951	819	867	775	938	858	877	832	958	937	995	888	989	997	854	883	948	863	843	726
Inventory	0.2%	1,934	1,931	2,039	2,110	2,074	2,073	2,012	1,924	1,692	1,670	1,700	1,676	1,673	1,578	1,524	1,301	1,400	1,371	1,322	1,278	1,250
Net PPE	3.9%	4,582	4,409	4,431	4,363	4,307	4,123	3,765	3,752	3,730	3,633	3,665	3,609	3,716	3,506	3,483	3,487	3,750	3,689	3,793	3,821	3,881
Goodwill	2.5%	3,410	3,327	3,373	3,375	3,352	418	3,238	3,292	3,284	3,685	3,753	3,701	3,824	3,711	3,628	3,559	3,508	923	2,536	2,517	2,530
Liabilities	-1.3%	15,436	15,637	15,912	15,748	14,925	15,235	15,153	14,995	14,069	14,853	15,137	15,138	14,819	14,393	14,409	14,729	14,476	14,852	13,161	13,093	11,964
Current Liabilities	3.0%	4,741	4,602	4,632	4,441	4,004	4,492	4,395	4,566	4,051	4,281	4,203	4,539	4,404	4,481	4,580	4,443	4,038	4,231	3,782	3,865	3,341
Long Term Debt	-5.4%	8,219	8,690	8,954	8,870	8,741	8,219	7,957	7,588	7,194	7,682	7,951	7,570	7,334	6,971	6,884	7,336	7,333	7,646	6,640	6,655	6,354
LT Debt, Current	25.0%	20.00	16.00	16.00	15.00	14.00	13.00	13.00	12.00	12.00	11.00	10.00	9.00	9.00	256	255	255	254	2.00	1.00	1.00	-
LT Debt, Non Current	-5.4%	8,219	8,690	8,954	8,870	8,741	8,219	7,957	7,588	7,194	7,682	7,951	7,570	7,334	6,971	6,884	7,336	7,333	7,646	6,640	6,655	6,354
Shareholder's Equity	-	609	-	24,258	431	401	431	390	3,355	3,269	1,466	1,466	3,011	358	23,052	2,666	2,623	1,466	-	21,653	1,466	299
Retained Earnings	2.9%	25,289	24,571	24,258	24,153	24,573	24,566	24,342	24,149	24,350	24,201	23,946	23,624	23,699	23,052	22,731	22,481	22,501	21,860	21,653	21,436	21,615
Additional Paid-In Capital	1.2%	3,808	3,762	3,688	3,603	3,546	3,518	3,402	3,355	3,269	3,174	3,085	3,011	2,969	2,837	2,666	2,623	2,488	2,466	2,338	2,241	2,204
Accumulated Depreciation	-100.0%	-	5,570	5,557	5,452	5,276	5,195	5,249	5,291	5,169	5,194	5,183	5,028	5,035	4,874	4,714	4,680	4,830	4,700	4,683	4,577	4,455
Shares Outstanding	-100.0%	-	823	827	830	-	835	834	838	-	843	844	846	-	857	857	857	-	857	858	859	-
Minority Interest	-16.1%	348	415	379	431	405	431	390	407	362	436	398	401	358	420	464	454	441	498	337	342	299
Float	-	-	-	63,600	-	-	-	66,800	-	-	-	68,600	-	-	-	62,800	-	-	-	61,300	-	-

Cashflow (Last 12 Months)

(In Millions)

Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	-1.4%	1,136	1,152	722	735	673	969	528	386	1,106	994	627	598	963	962	1,026	768	970	914	644	605	862
Share Based Compensation	-58.3%	25.00	60.00	23.00	14.00	20.00	60.00	16.00	29.00	28.00	49.00	20.00	38.00	22.00	53.00	16.00	16.00	17.00	49.00	17.00	17.00	12.00
Cashflow From Investing	11.2%	-143	-161	-174	-264	-173	-946	-341	-141	-130	-173	-147	-142	-111	-151	-58.00	-459	-24.00	-1,863	-114	-98.00	4.00
Cashflow From Financing	-17.3%	-992	-846	-580	-375	-666	99.00	-181	-204	-1,106	-784	-550	-334	-951	-827	-833	-308	-1,020	1,054	-512	-392	-978
Buy Backs	-26.2%	245	332	371	180	413	104	381	410	356	251	341	372	898	350	8.00	220	178	360	265	399	282

CL Income Statement

2023-12-31

Consolidated Statements of Income - USD ($) $ in Millions	12 Months Ended
Consolidated Statements of Income - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Net sales	$ 19,457	$ 17,967	$ 17,421
Cost of sales	8,131	7,719	7,046
Gross profit	11,326	10,248	10,375
Selling, general and administrative expenses	7,151	6,565	6,407
Other (income) expense, net	191	69	65
Goodwill and intangible assets impairment charges	0	721	571
Operating profit	3,984	2,893	3,332
Non-service related postretirement costs	360	80	70
Interest (income) expense, net	232	153	175
Income before income taxes	3,392	2,660	3,087
Provision for income taxes	937	693	749
Net income including noncontrolling interests	2,455	1,967	2,338
Less: Net income attributable to noncontrolling interests	155	182	172
Net income attributable to Colgate-Palmolive Company	$ 2,300	$ 1,785	$ 2,166
Earnings per common share, basic (in dollars per share)	$ 2.78	$ 2.13	$ 2.56
Earnings per common share, diluted (in dollars per share)	$ 2.77	$ 2.13	$ 2.55

CL Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Current Assets
Cash and cash equivalents	$ 966	$ 775
Receivables (net of allowances of $80 and $70, respectively)	1,586	1,504
Inventories	1,934	2,074
Other current assets	793	760
Total current assets	5,279	5,113
Property, plant and equipment, net	4,582	4,307
Goodwill	3,410	3,352
Other intangible assets, net	1,887	1,920
Deferred income taxes	214	135
Other assets	1,021	904
Total assets	16,393	15,731
Current Liabilities
Notes and loans payable	310	11
Current portion of long-term debt	20	14
Accounts payable	1,698	1,551
Accrued income taxes	336	317
Other accruals	2,377	2,111
Total current liabilities	4,741	4,004
Long-term debt	8,219	8,741
Deferred income taxes	361	383
Other liabilities	2,115	1,797
Total liabilities	15,436	14,925
Commitments and contingent liabilities	0	0
Shareholders’ Equity
Common stock, $1 par value (2,000,000,000 shares authorized, 1,465,706,360 shares issued)	1,466	1,466
Additional paid-in capital	3,808	3,546
Retained earnings	25,289	24,573
Accumulated other comprehensive income (loss)	(3,937)	(4,055)
Unearned compensation	0	(1)
Treasury stock, at cost	(26,017)	(25,128)
Total Colgate-Palmolive Company shareholders’ equity	609	401
Noncontrolling interests	348	405
Total equity	957	806
Total liabilities and equity	$ 16,393	$ 15,731

About Colgate-Palmolive Co

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

CEO	Mr. Noel R. Wallace
WEBSITE	colgatepalmolive.com
INDUSTRY	Household Products
EMPLOYEES	33800

Colgate-Palmolive Co Frequently Asked Questions

What is the ticker symbol for Colgate-Palmolive Co? What does CL stand for in stocks?

CL is the stock ticker symbol of Colgate-Palmolive Co. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Colgate-Palmolive Co (CL)?

As of Wed Apr 17 2024, market cap of Colgate-Palmolive Co is 71.41 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CL stock?

You can check CL's fair value in chart for subscribers.

What is the fair value of CL stock?

You can check CL's fair value in chart for subscribers. The fair value of Colgate-Palmolive Co is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Colgate-Palmolive Co is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CL so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Colgate-Palmolive Co a good stock to buy?

The fair value guage provides a quick view whether CL is over valued or under valued. Whether Colgate-Palmolive Co is cheap or expensive depends on the assumptions which impact Colgate-Palmolive Co's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CL.

What is Colgate-Palmolive Co's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Apr 17 2024, CL's PE ratio (Price to Earnings) is 31.05 and Price to Sales (PS) ratio is 3.67. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CL PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Colgate-Palmolive Co's stock?

In the past 10 years, Colgate-Palmolive Co has provided 0.047 (multiply by 100 for percentage) rate of return.